Revolution Medicines, Inc. RVMD
194.23 USD +6.06 (+3.22%)
At closeNov 3, 2026, 5:54 PM EST
195.00 +0.77 +0.40%
After hours · Nov 3, 5:54 PM ET
188.63 Day range 197.00
57.74 52-week range 224.31
- YTD
- +143.85%
- 1 year
- +227.37%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 258.84 +33.3% upside
Now 194.23
- Target (low)
- 179.00
- Target (mean)
- 258.84
- Target (high)
- 320.00
Ratings (0m) 25 24 buy · 1 hold · 0 sell
- Strong buy5
- Buy19
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 25
- 1 month ago 23
- 2 months ago 22
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -2.38 | -3.24 – -2.07 | -1.61 | -47.9% | 27.35M | 0.0% | 21 |
| Next quarter | -1.98 | -3.53 – -0.53 | -1.86 | -6.3% | 167.43M | 0.0% | 21 |
| Current year | -9.58 | -12.17 – -8.21 | -5.95 | -61.0% | 200.82M | 0.0% | 24 |
| Next year | -5.76 | -9.91 – -1.91 | -9.58 | +39.8% | 1.26B | +526.6% | 24 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Oct 19, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 16, 2026 | William Blair | Initiated | — | Outperform |
| Oct 15, 2026 | Needham | Reiterated | Buy | Buy |
| Oct 14, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Sep 28, 2026 | Brookline Capital | Initiated | — | Buy |
| Sep 21, 2026 | B of A Securities | Maintained | Buy | Buy |
| Sep 10, 2026 | Morgan Stanley | Initiated | — | Overweight |
| Sep 9, 2026 | Stifel | Maintained | Buy | Buy |
| Aug 31, 2026 | Needham | Maintained | Buy | Buy |
| Aug 28, 2026 | UBS | Maintained | Buy | Buy |
| Aug 28, 2026 | Guggenheim | Maintained | Buy | Buy |
| Aug 27, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 27, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 27, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Aug 27, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 27, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 27, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 21, 2026 | Bernstein | Maintained | Market Perform | Market Perform |
| Aug 11, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Guggenheim | Maintained | Buy | Buy |
| Aug 6, 2026 | Needham | Maintained | Buy | Buy |
| Jul 23, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Jul 20, 2026 | Needham | Maintained | Buy | Buy |
| Jul 9, 2026 | Guggenheim | Maintained | Buy | Buy |